Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
暂无分享,去创建一个
Limin Zhang | Costas D. Maranas | Frank J. Gonzalez | Emmanuel Hatzakis | Changtao Jiang | Andrew D. Patterson | Margaret N. Simons | C. Maranas | S. H. Chan | F. Gonzalez | A. Patterson | Changtao Jiang | Cen Xie | Philip B. Smith | Limin Zhang | E. Hatzakis | Cen Xie | Robert G. Nichols | Siu H. J. Chan | Ruixin Hao | Jingwei Cai | Jingwei Cai | Ruixin Hao
[1] H. Goossens,et al. Differences in gut microbiota composition between obese and lean children: a cross-sectional study , 2013, Gut Pathogens.
[2] Jeffrey D Orth,et al. What is flux balance analysis? , 2010, Nature Biotechnology.
[3] Sarah L. Westcott,et al. Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform , 2013, Applied and Environmental Microbiology.
[4] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[5] E. Murphy,et al. Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent Challenge , 2013, PloS one.
[6] G. Perdew,et al. Metabolomics Reveals that Aryl Hydrocarbon Receptor Activation by Environmental Chemicals Induces Systemic Metabolic Dysfunction in Mice. , 2015, Environmental science & technology.
[7] Simon W. Beaven,et al. Intestinal farnesoid X receptor puts a fresh coat of wax on fatty liver , 2015, Hepatology.
[8] A. Martí,et al. Genes, lifestyles and obesity , 2004, International Journal of Obesity.
[9] Bernard Henrissat,et al. Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome , 2012, PLoS Comput. Biol..
[10] B. Roe,et al. A core gut microbiome in obese and lean twins , 2008, Nature.
[11] F. Bäckhed,et al. Microbiota-induced obesity requires farnesoid X receptor , 2016, Gut.
[12] I. Albert,et al. Persistent Organic Pollutants Modify Gut Microbiota–Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation , 2015, Environmental health perspectives.
[13] F. Gonzalez,et al. Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity , 2015, Journal of hepatology.
[14] Takuma Tsuchida,et al. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. , 2012, Metabolism: clinical and experimental.
[15] F. Schütz,et al. Hepatic glucose sensing is required to preserve β cell glucose competence. , 2013, The Journal of clinical investigation.
[16] S. Sørensen,et al. Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.
[17] Karine Clément,et al. Genetics of human obesity. , 2006, The Proceedings of the Nutrition Society.
[18] M. J. Saad,et al. Gut microbiota composition and its effects on obesity and insulin resistance , 2014, Current opinion in clinical nutrition and metabolic care.
[19] F. Bäckhed,et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. , 2013, Cell metabolism.
[20] Lee M. Kaplan,et al. Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity , 2013, Science Translational Medicine.
[21] R. Mahadevan,et al. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. , 2003, Metabolic engineering.
[22] Jesse R. Zaneveld,et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.
[23] W. D. de Vos,et al. Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data , 2013, PeerJ.
[24] I. Albert,et al. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. , 2015, The Journal of clinical investigation.
[25] William H. Bisson,et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction , 2015, Nature Communications.
[26] C. Hill,et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut , 2014, Proceedings of the National Academy of Sciences.
[27] H. Inadera,et al. Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals , 2013, Environmental Health and Preventive Medicine.
[28] P. Vajro,et al. Microbiota and Gut–Liver Axis: Their Influences on Obesity and Obesity-Related Liver Disease , 2013, Journal of pediatric gastroenterology and nutrition.
[29] J. Montani,et al. Substrate cycling between de novo lipogenesis and lipid oxidation: a thermogenic mechanism against skeletal muscle lipotoxicity and glucolipotoxicity , 2004, International Journal of Obesity.
[30] A. Irving,et al. New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.
[31] B. Staels,et al. Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.
[32] T. Asano,et al. Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity. , 2005, Diabetes.
[33] A. Schwiertz,et al. Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.
[34] P. Hylemon,et al. Bile acids and the gut microbiome , 2014, Current opinion in gastroenterology.
[35] B. Staels,et al. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[36] D. Brenner,et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance , 2015, Nature Medicine.
[37] V. de Lédinghen,et al. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. , 2011, Journal of hepatology.
[38] James B. Mitchell,et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity , 2013, Nature Communications.
[39] S. Daniels,et al. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, , 2003, Circulation.
[40] Fei Li,et al. FXR signaling in the enterohepatic system , 2013, Molecular and Cellular Endocrinology.
[41] Barbara M. Bakker,et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.
[42] E. Murphy,et al. The gut microbiota and its relationship to diet and obesity , 2012, Gut microbes.
[43] Martin Hartmann,et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.
[44] Masahiro Tohkin,et al. Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.